Note: Ingredients listed on restricted chemical lists
General Information
Version
6.0
Revision date
2025-12-13
Product name
Vericiguat Formulation
1.2.1 Relevant identified uses
Pharmaceutical
supplier name
Merck & Co., Inc
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Other hazards
Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. Hazards associated with a change in physical form Conditions Hazards If small particles are generated during further May form combustible dust concentrations in processing, handling or by other means. air.
Signal word
Danger
Hazard statements
H372 Causes damage to organs (Cardio-vascular system) through prolonged or repeated exposure if swallowed.
Prevention
P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P314 Get medical attention if you feel unwell.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
2.1 Classification of the substance or mixture
1910.1200) Hazards for the product as supplied Specific target organ toxicity : Category 1 (Cardio-vascular system) - repeated exposure (Oral) Other hazards Dust contact with the eyes can lead to mechanical irritation. Contact with dust can cause mechanical irritation or drying of the skin. Hazards associated with a change in physical form: Conditions Hazards If small particles are generated during further May form combustible dust concentrations in processing, handling or by other means. air.
